Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Corcept Therapeutics Incorporated

Corcept Therapeutics shares gained 15 percent on over 1.6 million shares traded Friday. Analysts at Piper Jaffray have upgraded the company’s rating from “underweight” to “overweight”, while analysts at Janney Capital initiated coverage on the company with a “buy” rating.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on